medgenesis.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Medgenesis Therapeutix |
| Description | MedGenesis Therapeutix Inc. is a private Canadian biopharmaceutical holding company, with interests in seeing through to commercialization innovative treatments, including their various needed |
| Keywords | Medgenesis |
Server Information
| WebSite | |
| Host IP | 162.214.66.247 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
medgenesis.com Valuation
|
US$2,031,341
Last updated: 2023-05-07 06:48:27
medgenesis.com has Semrush global rank of 5,210,502. medgenesis.com has an estimated worth of US$ 2,031,341, based on its estimated Ads revenue. medgenesis.com receives approximately 234,386 unique visitors each day. Its web server is located in United States, with IP address 162.214.66.247. According to SiteAdvisor, medgenesis.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$2,031,341 |
| Daily Ads Revenue | US$1,876 |
| Monthly Ads Revenue | US$56,253 |
| Yearly Ads Revenue | US$675,031 |
| Daily Unique Visitors | 15,626 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| medgenesis.com. | A | 7199 | IP: 162.214.66.247 |
| medgenesis.com. | NS | 86400 | NS Record: ns1.greslie.com. |
| medgenesis.com. | NS | 86400 | NS Record: ns2.greslie.com. |
| medgenesis.com. | MX | 86400 | MX Record: 0 medgenesis-com.mail.protection.outlook.com. |
| medgenesis.com. | TXT | 86400 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
| medgenesis.com. | TXT | 86400 | TXT Record: MS=ms80100266 |
HtmlToTextCheckTime:2023-05-07 06:48:27
| Home About Us News Board of Directors Contact Us MedGenesis Therapeutix Inc. (MedGenesis) is a private Canadian biopharmaceutical holding company with properties in the neurological space. These include components of potentially innovative treatments for patients with neurological disorders, with a focus on Parkinson’s disease. Until recently, MedGenesis led the clinical development of glial cell-line derived neurotrophic factor (GDNF) for the definitive treatment of Parkinson’s disease, before selling the program to Vivifi Biotech Ltd, a wholly owned subsidiary of the Parkinson’s Society of the United Kingdom (PUK). MedGenesis maintains a significant economic interest in the program and is supporting it through the sale to Vivifi of other IP assets, deemed critical for the eventual commercialization of the program, if clinical results warrant it. 24-Feb-2021 Parkinson’s UK creates Vivifi Biotech to research ’promising’ experimental treatment Charity organisation Parkinson’s UK has |
HTTP Headers
HTTP/1.1 301 Moved Permanently Content-Length: 146 Content-Type: text/html; charset=UTF-8 Location: https://medgenesis.com/ Server: Microsoft-IIS/10.0 X-Powered-By: ASP.NET X-Powered-By-Plesk: PleskWin Date: Wed, 27 Oct 2021 13:08:43 GMT HTTP/2 200 content-length: 3953 content-type: text/html last-modified: Thu, 03 Jun 2021 16:58:05 GMT accept-ranges: bytes etag: "808ce89e9958d71:0" server: Microsoft-IIS/10.0 x-powered-by: ASP.NET x-powered-by-plesk: PleskWin date: Wed, 27 Oct 2021 13:08:43 GMT |
medgenesis.com Whois Information
Domain Name: MEDGENESIS.COM Registry Domain ID: 99557507_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2021-04-24T06:52:11Z Creation Date: 2003-06-23T13:23:45Z Registry Expiry Date: 2022-06-23T13:23:45Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.GRESLIE.COM Name Server: NS2.GRESLIE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-15T10:09:40Z <<< |